Efficacy and Safety of Deucravacitinib in Adults with Alopecia Areata (IM011-134)
Active, not recruiting
- Conditions
- Alopecia Areata
- Registration Number
- jRCT2031220610
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Documented clinical diagnosis of AA for at least 6 months Alopecia Areata Investigator Global Assessment ( AA-IGA) grade >- 3
Exclusion Criteria
Other active skin diseases affecting the scalp that in the opinion of the investigator may interfere with accurate assessment of SALT score History or evidence of active infection and/or febrile illness Any ongoing treatment known to affect hair growth
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method - SALT score
safety and tolerability
- Secondary Outcome Measures
Name Time Method